EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Emergency coronary angiography in a 90-plus population – outcomes at 5-year follow-up

Tânia Proença, Ricardo Alves Pinto, Miguel Martins Carvalho, Paula Dias, Filipe Macedo

Monaldi Archives for Chest Disease · 2023-02-21

DOI: 10.4081/monaldi.2023.2526 ↗
AbstractBibliografische Angaben

Abstract

Elderly people represent a vulnerable and increasing population presenting with acute coronary syndrome (ACS). Our goal was to evaluate a group of very old patients who underwent emergency coronary angiography (CA). We retrospectively analyzed a group of very old patients (≥90-year-old) who underwent emergency CA from 2008 to 2020. Survival and MACE [a composite of all-cause death, ischemic stroke, ACS or hospitalization for acute heart failure] were compared with an aged-matched control population with ACS not submitted to emergency CA. A total of 34 patients were enrolled, 56% female, median age of 92-year-old. Almost all patients had STE-ACS. In CA, 65% had multivessel disease and coronary intervention was performed in 71%. More than one-third evolved in Killip class III/IV and 70% had left ventricular dysfunction. Regarding mortality, 38% of patients died in the index event versus 25% in the aged-matched control group (p=0.319). During five years of follow-up, there was no significant difference in mortality between the two groups (Log-rank = 0.403) and more than 50% of patients died in two years. Comparing MACE occurrence, both groups were similar (Log-rank = 0.662), with more than 80% having at least one event in five years. Very-old patients submitted to emergency CA had a high rate of multivessel disease and left ventricular dysfunction, in-hospital and follow-up mortality, and MACE. Compared to an aged-matched control group not submitted to emergency CA, they showed no survival or MACE benefit during a 5-year follow-up.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →